By now, we’re all (hopefully) getting accustomed to the concept of “patient-centricity.” However, another commonly overlooked but equally important group of healthcare stakeholders is careg
Insulin has been used to manage diabetes for a century, and while many advances have been made for people with both type 1 and type 2 diabetes – many more continue to be made.
Regulators and health technology assessment (HTA) bodies are increasingly demanding the patient voice play a central role in drug development – making it riskier for developers to ignore th
There are between 6000 and 8000 rare diseases in the world, and one in ten people in Europe and the U.S have a rare disease; 75% of rare diseases affect children, and 30% of rare disease patients d
